StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27+0.00 (+0.37%)

Close on Nov 18, 2026Market cap $2.89MP/E –Yield –

Gelteq r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was A$628.61K, up 127.7% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$628.61K+127.7%
FY2024Jun 30, 2024A$276.06K-58.5%
FY2023Jun 30, 2023A$665.04K–

More Gelteq figures

See a number that looks wrong?